FDCDDQ
IOVA icon

Federation des caisses Desjardins du Quebec’s Iovance Biotherapeutics IOVA Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27K Buy
6,500
+250
+4% +$950 ﹤0.01% 2103
2026
Q1 		$21.9K Buy
6,250
+1,000
+19% +$3.2K ﹤0.01% 2082
2025
Q4 		$14.3K Hold
5,250
– – ﹤0.01% 2143
2025
Q3 		$11.4K Buy
5,250
+3,000
+133% +$7.08K ﹤0.01% 2222
2025
Q2 		$3.87K Hold
2,250
– – ﹤0.01% 2308
2025
Q1 		$7.49K Hold
2,250
– – ﹤0.01% 2051
2024
Q4 		$16.6K Buy
2,250
+600
+36% +$5.56K ﹤0.01% 1730
2024
Q3 		$15.5K Buy
+1,650
New +$15.6K ﹤0.01% 1743

Other funds holding IOVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's IOVA Position: Q2 2026 in Review

Federation des caisses Desjardins du Quebec increased its Iovance Biotherapeutics (IOVA) stake by 4% in Q2 2026, buying an estimated $950 and bringing the position to 6,500 shares worth $27K. The position accounts for ﹤0.01% of the portfolio, ranked #2103.

Federation des caisses Desjardins du Quebec first reported a position in IOVA in Q3 2024 and has held it in 8 quarters since. 292 funds tracked by Wall St. Rank hold IOVA as of Q2 2026.

  • Federation des caisses Desjardins du Quebec held 6,500 shares of Iovance Biotherapeutics worth $27K as of Q2 2026.
  • Federation des caisses Desjardins du Quebec bought 250 Iovance Biotherapeutics shares in Q2 2026, an estimated $950.
  • Iovance Biotherapeutics made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q2 2026, its #2103 holding.
  • Federation des caisses Desjardins du Quebec first reported a position in Iovance Biotherapeutics in Q3 2024 and has held it in 8 quarters since.
  • 292 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2026, filed 14 Aug 2026.